APRETUDE
APRETUDE (cabotegravir) is an FDA-approved long-acting injectable medication used for HIV-1 pre-exposure prophylaxis (PrEP) in at-risk adults and adolescents weighing at least 35 kg. Each preservative-free 1×3 mL single-dose vial is designed for intramuscular administration by a healthcare professional once every two months after initial loading doses. APRETUDE provides consistent protection against HIV infection without the need for daily oral PrEP, helping improve adherence and patient outcomes.
InfusionMed USA, headquartered in Carrollton, Texas, supplies APRETUDE and other specialty injectable medications to hospitals, clinics, and mobile IV therapy providers throughout Dallas, Frisco, McKinney, The Colony, Lewisville, Plano, and neighboring North Texas areas. We follow FDA-compliant storage, temperature-controlled logistics, and timely delivery to ensure product integrity from order to administration.
Available only for licensed healthcare professionals and infusion centers.
Download Form